The Milan group evaluated HCC surveillance by semiannual ultrasound evaluation and serum AFP determination in 258 patients with HBV-compensated cirrhosis who were receiving antivirals and had normal aminotransferases and normal serum AFP levels (≤7 ng/mL) at baseline. Here, AFP is linked to hepatocellular carcinoma.